Enteric Disease Testing Market, By Testing, By Disease, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

REPORT HIGHLIGHT

Enteric Disease Testing Market size was valued at USD 3,987 Million in 2024, expanding to a CAGR of 3.5% from 2025 to 2032.

Enteric disease testing refers to the diagnostic process used to identify infections that affect the gastrointestinal (GI) tract, particularly those that are transmitted through contaminated food, water, or contact with infected individuals or animals. These diseases are typically caused by bacteria, viruses, or parasites, and testing helps determine the specific cause of symptoms such as diarrhea, vomiting, fever, etc.

Enteric Disease Testing Market- Market Dynamics

Growing incidence of enteric infections and rising emphasis on food & water safety along with advanced tech is expected to propel market demand
The Enteric Disease Testing market is boosted by the increasing global incidence of enteric diseases. These infections, caused by bacteria, viruses, and parasites, are often linked to contaminated water, food, and poor sanitation. According to the World Health Organization (WHO), diarrheal diseases are the second leading cause of death in children under five, with many cases stemming from enteric pathogens. With growing urban populations, overcrowded environments, and inconsistent access to clean water, the transmission of these diseases has surged, creating a greater demand for diagnostic testing.
In addition, governments, NGOs, and international organizations have intensified their efforts in promoting food and water safety. Enteric pathogens like Salmonella, E. coli, and Listeria are frequently implicated in foodborne illness outbreaks. As a result, there is rising pressure on food producers and water treatment facilities to adopt regular and rigorous testing protocols. The implementation of safety regulations like the Food Safety Modernization Act (FSMA) in the United States has accelerated the demand for pathogen detection methods in food and water supply chains. The shift from conventional stool cultures to more sophisticated molecular diagnostics such as polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), and next-generation sequencing (NGS) has significantly improved the sensitivity and speed of detection, accelerating market growth.

Enteric Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.5% over the forecast period (2025-2032)
Based on Testing segmentation, the rapid testing segment was predicted to show maximum market share in the year 2024, due to its real-time test results.
Based on Disease segmentation, the bacteria segment was the leading Disease segment in 2024, due to the diseases caused by bacteria like salmonella, shigella, E-coil, etc.
Based on End Use segmentation, the food segment was the leading End Use segment in 2024, owing to high food safety concerns due to pathogen transmission.
Based on the region, Asia Pacific was the leading revenue generator in 2024, owing to high demand for advanced diagnostic technology.

Enteric Disease Testing Market- Segmentation Analysis:

The Global Enteric Disease Testing Market is segmented based on Testing, Disease, End Use, and Region.
The market is divided into five categories based on Testing: rapid, traditional, PCR, immunoassay, and chromatography. The rapid segment dominates the market. The increasing demand for quick results & testing, and convenience is fueling segment growth.
The market is divided into three categories based on Disease: bacterial, viral, and parasitic. The bacterial segment is expected to hold the largest share as bacteria like salmonella, shigella, E-coil campylobacter infections are rising.
The market is divided into three categories based on End Use: water and food. The food segment holds the highest share of the End Use segment. The increase in the demand for convenience foods, including packed foods, frozen food products, is contributing to market growth.

Enteric Disease Testing Market- Geographical Insights

Across the globe, the Enteric Disease Testing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America, especially the United States, holds a significant share of the global market. Asia Pacific is expected to witness the fastest growth due to increasing cases of waterborne and foodborne illnesses. A large population and rising urbanization lead to poor sanitation in some areas. Moreover, rising investments in low-cost, rapid testing kits for use in rural areas are fueling regional growth. NGO-led programs (WHO) funding enteric disease management and increasing investment in healthcare infrastructure owing to rising awareness of testing. In Europe, there is a focus on public health surveillance and hospital infection control and high awareness of antimicrobial resistance (AMR).

Enteric Disease Testing Market- Competitive Landscape:

The enteric disease diagnostics market is highly competitive, with companies focusing on technological innovation, rapid diagnostics, and multiplex testing panels. Multiplex panels are replacing traditional culture methods. One test can detect multiple pathogens, saving time and improving diagnostic yield. Companies are investing heavily in India, Brazil, and African countries to improve healthcare infrastructure. Also, market players are engaging in new product launches, innovation for rapid diagnostics.

Recent Developments:

In April 2024, deployment of around 1.2 million cholera rapid diagnostic testing carried out in Malawi by UNICEF, WHO, etc.
In 2024, Thermo Fisher Scientific invested in AI-powered analytics for food pathogen surveillance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENTERIC DISEASE TESTING MARKET KEY PLAYERS

BioMérieux
BD (Becton, Dickinson and Company)
Thermo Fisher Scientific
Roche Diagnostics
Abbott Laboratories
QIAGEN
DiaSorin
Meridian Bioscience
Hologic Inc.
Cepheid
Siemens Healthineers
Danaher Corporation
Agilent Technologies
Merck KGaA
Intertek
Bio-Rad Laboratories
Others

GLOBAL ENTERIC DISEASE TESTING MARKET, BY TESTING- MARKET ANALYSIS, 2019-2032

Rapid
Traditional
PCR
Immunoassay
Chromatography

GLOBAL ENTERIC DISEASE TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019-2032

Bacterial
Viral
Parasitic

GLOBAL ENTERIC DISEASE TESTING MARKET, BY END USE- MARKET ANALYSIS, 2019-2032

Water
Food

GLOBAL ENTERIC DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA Show more